Functional immune changes are conserved in COVID-19 and trauma patients receiving intensive care
Nature Communications·
- DOI
- 10.1038/s41467-026-75748-5
- PMID
- 42642368
- PMCID
- —
- OpenAlex
- W4414617512
- Study type
- Cohort study
- Publisher
- Springer Science and Business Media LLC
- Article type
- journal-article
- Integrity
- current
Why this research matters now
The demonstration of shared immune alterations across distinct critical illnesses suggests that similar targeted immunomodulation strategies may benefit multiple patient populations in intensive care settings.
Structured evidence summary
Research question
The study compared immune function changes in critically ill COVID-19 and trauma patients to identify shared pathobiological mechanisms that could inform precision therapies.
Study design
This was a prospective cohort study with longitudinal sampling at days 1, 3, and 5 of ICU admission. The analysis included plasma protein measurement, immune cell phenotyping, and functional responses to S. aureus bioparticles, with unsupervised multi-omics factor analysis applied to identify shared biological variation.
Population and setting
The study enrolled 26 COVID-19 patients, 20 trauma patients receiving intensive care, and 18 healthy controls.
Main findings
Both COVID-19 and trauma patients showed neutrophilia, reduced non-classical monocytes and dendritic cells, and hyper-phagocytic neutrophils with elevated reactive oxygen species production compared to controls. Classical monocytes from both patient groups failed to upregulate CD11c, CD86, and SIRPα upon stimulation. A phagocytosis-impaired SIRPα-negative CD11b-negative dendritic cell population was enriched from day 1, and innate immune activation profiles were associated with impaired innate-adaptive crosstalk.
Public-health relevance
The demonstration of shared immune alterations across distinct critical illnesses suggests that similar targeted immunomodulation strategies may benefit multiple patient populations in intensive care settings.
Important limitations
This summary is limited to the supplied single-article abstract and metadata. Full interpretation of study limitations, including sample size considerations, generalizability, and mechanistic depth, requires review of the complete published article.
GIDS interpretation
The article was classified under SARS and COVID-19 disease terms, reflecting its focus on immune dysfunction in COVID-19 patients. The comparative design with trauma patients supports discoverability for research on critical illness immunology broadly, not solely pandemic-specific pathology.
Related GIDS surveillance
Literature context does not validate, explain, or change a surveillance signal. Exact and contextual relationships are shown separately.
Evidence relationships
This article has 7 auditable classifier relationships to diseases, places, topics, and study design.